Synlab AG SYAB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SYAB is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- €10.50
- Day Range
- €10.48–10.56
- 52-Week Range
- €6.72–24.80
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €2.31 Bil
- Volume/Avg
- 0 / 37,558
Key Statistics
- Price/Earnings (Normalized)
- 80.88
- Price/Sales
- 0.88
- Dividend Yield (Trailing)
- 3.14%
- Dividend Yield (Forward)
- 3.14%
- Total Yield
- 3.14%
Company Profile
Synlab AG is a medical diagnostics services provider in Europe. It offers a range of medical diagnostic services for practising doctors, clinics, and patients. Its geographical segments include France; Germany; South and North and East. The company derives a majority of revenue from the North and East.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Core
- Total Number of Employees
- 27,000
- Website
- https://www.synlab.com
Comparables
Valuation
|
Metric
|
SYAB
|
EUZ
|
BSL
|
|---|---|---|---|
Price/Earnings (Normalized) | 80.88 | 24.29 | 37.61 |
Price/Book Value | 0.99 | 3.38 | 2.30 |
Price/Sales | 0.88 | 3.05 | 1.56 |
Price/Cash Flow | 8.25 | 15.50 | — |
Price/Earnings
SYAB
EUZ
BSL
Financial Strength
|
Metric
|
SYAB
|
EUZ
|
BSL
|
|---|---|---|---|
Quick Ratio | 1.03 | 1.53 | 1.85 |
Current Ratio | 1.16 | 2.79 | 2.96 |
Interest Coverage | 2.17 | 11.38 | −10.43 |
Quick Ratio
SYAB
EUZ
BSL
Profitability
|
Metric
|
SYAB
|
EUZ
|
BSL
|
|---|---|---|---|
Return on Assets (Normalized) | 0.86% | 7.27% | −6.48% |
Return on Equity (Normalized) | 1.87% | 14.33% | −12.46% |
Return on Invested Capital (Normalized) | 2.44% | 12.18% | −7.58% |
Return on Assets
SYAB
EUZ
BSL
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Llrfnrczk | Jkybw | $209.3 Bil | |
DHR
| Danaher Corp | Yjccnpjsx | Zywqqr | $182.1 Bil | |
IQV
| IQVIA Holdings Inc | Lnvfrrylx | Jqpjk | $42.8 Bil | |
IDXX
| IDEXX Laboratories Inc | Dckstktw | Hwxnq | $41.5 Bil | |
A
| Agilent Technologies Inc | Mzqqqzpmj | Pmxq | $40.4 Bil | |
MTD
| Mettler-Toledo International Inc | Vtmlnzvg | Bltwpf | $26.5 Bil | |
ICLR
| Icon PLC | Bkdtfvbz | Ybmszj | $24.8 Bil | |
ILMN
| Illumina Inc | Gpvjblmqs | Qqrvsk | $19.5 Bil | |
WAT
| Waters Corp | Pjxhpxbqqm | Mnjnf | $18.5 Bil | |
LH
| Laboratory Corp of America Holdings | Nglzdzhmvz | Djkyc | $16.7 Bil |